Skip to main content

Market Overview

Myriad Genetics Falling In After Hours (MYGN, CEPH)

Share:

Shares of Myriad Genetics (NASDAQ: MYGN) have fallen 9.64% to $22.50 in the after hours trading session. The stock closed normal market hours down 0.92% at $24.90. The activity in the name appears to be as a result of an announcement that the company has lost a U.S. court ruling that challenged its patents on a method of detecting inherited breast cancer.

U.S. District Judge Robert Sweet in New York ruled the patents invalid today, saying they “are directed to a law of nature and were therefore improperly granted.” According to a Business Week article, "Patents aren’t allowed for rules of nature, natural phenomena or abstract ideas." Keep an eye on MYGN tomorrow morning, as the stock should trade a lot of volume and be volatile.

Another name that is falling in the after hours, is Cephalon (NASDAQ: CEPH). This stock has lost nearly 5% and is trading at $69.00. Cephalon, like Myriad Genetics, is a biopharmaceutical company.

 

Related Articles (CEPH + MYGN)

View Comments and Join the Discussion!

Posted-In: Business WeekNews After-Hours Center Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com